1. Local anesthetic is cleared from the subarachnoid space by two principal routes: vascular uptake into the spinal cord and pial vessels, and bulk cerebrospinal fluid (CSF) flow carrying drug rostrally. For a highly lipid-soluble agent such as bupivacaine or tetracaine, which route predominates, and what is the practical consequence?
A) Bulk CSF flow predominates, producing rapid rostral spread and a uniformly high block
B) Vascular uptake into cord and adjacent tissue predominates, producing a relatively localized block that persists until tissue concentrations fall
C) Renal clearance predominates, so block duration tracks the patient's creatinine clearance
D) Hepatic first-pass metabolism predominates, terminating the block within minutes
E) Neither route is relevant because lipophilic agents are not cleared from CSF at all
ANSWER: B
Rationale:
Highly lipid-soluble agents such as bupivacaine and tetracaine are removed from the subarachnoid space primarily by vascular uptake into the spinal cord and adjacent pial vessels rather than by bulk CSF flow. Because the drug is taken up locally where it was deposited, the block is comparatively localized and persists until tissue concentrations decline, which is one reason these agents produce dense, long-duration spinal anesthesia.
Option A: Option A describes the behavior more characteristic of less lipid-soluble agents, in which bulk CSF flow contributes more to clearance and spread; it does not describe lipophilic agents.
Option C: Option C is incorrect because clearance from the CSF compartment is governed by local vascular uptake, not by renal function.
Option D: Option D is incorrect because hepatic metabolism governs systemic elimination after the drug has already left the CSF, not termination of the spinal block itself.
Option E: Option E is incorrect because lipophilic agents are indeed cleared from CSF, chiefly by vascular uptake.
2. A clinician selects an isobaric (plain) bupivacaine 0.5% solution rather than a hyperbaric preparation for a spinal anesthetic. How does the behavior of an isobaric solution differ from that of a hyperbaric solution within the subarachnoid space?
A) An isobaric solution rises toward the head regardless of position, producing a reliably high block
B) An isobaric solution sinks to the most dependent region exactly as a hyperbaric solution does
C) An isobaric solution must always be given with the patient head-down to reach an adequate level
D) An isobaric solution remains roughly at the level of injection with limited positional influence, so block level is more predictable from dose and injection site but less manipulable by patient position
E) An isobaric solution produces no block because it lacks the dextrose needed for neural penetration
ANSWER: D
Rationale:
An isobaric solution has a density essentially equal to that of CSF, so gravity exerts little net effect on it. It tends to stay near the level of injection with limited positional influence; the block level is therefore more predictable from the dose and the site of injection but cannot be steered by patient positioning the way a hyperbaric solution can. This is the central discrimination between isobaric and hyperbaric spinal anesthesia.
Option A: Option A describes a hypobaric solution, which is lighter than CSF and rises; it does not describe isobaric behavior.
Option B: Option B describes hyperbaric behavior, the opposite of isobaric.
Option C: Option C is incorrect because an isobaric solution does not depend on head-down positioning to establish its level.
Option E: Option E is incorrect because dextrose alters baricity, not the intrinsic anesthetic activity of the drug; an isobaric solution produces effective block.
3. For a brief ambulatory spinal anesthetic, an attending warns against one historically popular agent because of its notably high rate of transient neurologic symptoms (TNS), favoring instead an agent that essentially avoids this problem. Which pairing correctly identifies the agent associated with a high TNS rate and the preferred low-TNS alternative?
A) Hyperbaric lidocaine 5% carries a clinically significant TNS incidence, whereas preservative-free chloroprocaine essentially avoids TNS at clinical doses
B) Preservative-free chloroprocaine carries the high TNS rate, whereas hyperbaric lidocaine essentially avoids it
C) Hyperbaric bupivacaine 0.5% carries the high TNS rate, whereas tetracaine essentially avoids it
D) Both lidocaine and chloroprocaine carry identical, negligible TNS rates, so the distinction does not exist
E) TNS is unrelated to agent choice and depends only on needle gauge
ANSWER: A
Rationale:
Hyperbaric lidocaine 5% is associated with a clinically significant incidence of transient neurologic symptoms (TNS) — self-limited buttock and lower-extremity pain after block resolution — reported across a wide range in published series. Preservative-free chloroprocaine, by contrast, provides a short-duration spinal with essentially no meaningful TNS at clinical doses, which is a major reason it has displaced lidocaine for ambulatory spinals.
Option B: Option B reverses the correct association.
Option C: Option C is incorrect because bupivacaine and tetracaine are not the agents centrally implicated in the lidocaine TNS problem.
Option D: Option D is incorrect because the agents do not carry identical negligible rates; lidocaine's higher TNS rate is the whole basis for the preference.
Option E: Option E is incorrect because, although technique factors exist, TNS risk is strongly agent-dependent, with lidocaine being the principal offender.
4. Two patients of similar height receive the same milligram dose of hyperbaric spinal bupivacaine, yet one achieves a substantially higher block level. Which set of patient factors is most consistent with an increased cephalad spread of a given intrathecal dose?
A) Young age, non-pregnant state, low body weight, and tall stature
B) High CSF volume from any cause, which dilutes the drug and raises the block
C) Advanced age, term pregnancy, obesity, and short stature, each of which reduces effective CSF volume so a given dose spreads higher
D) Recent vigorous exercise and a high fluid intake immediately before the block
E) A faster injection of a hypobaric rather than hyperbaric solution
ANSWER: C
Rationale:
A given mass of intrathecal drug spreads to a higher level when the effective CSF volume is reduced, because the same dose is distributed through a smaller compartment. Advanced age (narrowing of the space by ligamentous hypertrophy and osteophytes), term pregnancy (engorged epidural veins compressing the subarachnoid space), obesity (raised intra-abdominal pressure transmitted to the epidural space), and short stature (smaller absolute subarachnoid volume) all reduce effective CSF volume and thereby increase cephalad spread. Option A lists the opposite profile, associated with relatively lower spread.
Option B: Option B inverts the relationship; higher CSF volume tends to lower, not raise, the block.
Option D: Option D describes factors that are not established determinants of spread.
Option E: Option E confuses baricity and injection technique with the patient factors the question asks about, and a hypobaric solution behaves differently from the hyperbaric agent specified.
5. The standard epidural test dose (3 mL of lidocaine 1.5% with epinephrine 1:200,000) is designed to detect two distinct catheter misplacements using two different markers. Which option correctly matches each marker to the misplacement it reveals?
A) The epinephrine reveals intrathecal placement, and the lidocaine reveals intravascular placement
B) Both the epinephrine and the lidocaine reveal intravascular placement, and neither detects intrathecal placement
C) Both the epinephrine and the lidocaine reveal intrathecal placement, and neither detects intravascular placement
D) The epinephrine reveals subdural placement, and the lidocaine reveals epidural placement
E) The epinephrine (about 15 micrograms) reveals intravascular placement by producing a brisk rise in heart rate, and the lidocaine (about 45 mg) reveals intrathecal placement by producing a rapid dense motor block
ANSWER: E
Rationale:
The two components of the test dose target two different errors. The roughly 15 micrograms of epinephrine, if delivered intravascularly, produces a brisk transient rise in heart rate within about a minute, marking intravascular catheter placement. The roughly 45 mg of lidocaine, if delivered intrathecally, acts as a meaningful spinal dose and produces a rapidly developing dense motor block within a few minutes, marking subarachnoid placement. Matching each marker to its compartment is the core of the test-dose concept. Option D misassigns the markers to subdural and epidural placement, which the test dose is not designed to discriminate.
Option A: Option A reverses the two markers.
Option B: Option B incorrectly assigns both markers to the intravascular error and ignores intrathecal detection.
Option C: Option C incorrectly assigns both markers to the intrathecal error and ignores intravascular detection.
6. A patient maintained on a beta-adrenergic blocker is to receive an epidural with a standard epinephrine-containing test dose. Why is the test dose less reliable in this patient, and what should the clinician do?
A) The beta-blocker exaggerates the heart rate response, so any tachycardia should be ignored as artifact
B) The beta-blocker blunts or abolishes the epinephrine-induced heart rate rise, so the clinician must rely on alternative markers of intravascular injection such as a rise in blood pressure, palpitations, or T-wave changes on continuous ECG
C) The beta-blocker prevents the lidocaine from producing motor block, eliminating intrathecal detection
D) The beta-blocker converts the epinephrine into an inactive metabolite before it reaches the heart
E) No adjustment is needed because beta-blockers have no effect on the epinephrine marker
ANSWER: B
Rationale:
The epinephrine marker depends on a beta-mediated rise in heart rate. In a patient on a beta-adrenergic blocker, that chronotropic response is blunted or absent, so a negative heart rate response cannot be trusted to exclude intravascular placement. The clinician must instead watch for alternative signs of intravascular injection, such as an abrupt rise in blood pressure, palpitations, or T-wave changes on continuous ECG.
Option A: Option A is incorrect and dangerous because it tells the clinician to ignore a potentially real signal; the problem is a falsely absent response, not an exaggerated one.
Option C: Option C is incorrect because the lidocaine motor-block marker for intrathecal placement is not abolished by beta-blockade.
Option D: Option D fabricates a metabolic mechanism; beta-blockers do not inactivate epinephrine in this way.
Option E: Option E is incorrect because beta-blockade specifically undermines the reliability of the epinephrine marker.
7. A laboring patient with a functioning epidural catheter requires urgent conversion to surgical anesthesia for cesarean delivery. Which agent provides the fastest and most reliable onset of a dense surgical block through the existing catheter, and what accounts for its speed?
A) 3% chloroprocaine, because its very high concentration overcomes its ionization disadvantage by mass action, producing the most rapid surgical block (about 6 to 10 minutes)
B) 0.0625% bupivacaine, because its low concentration penetrates nerves fastest
C) Intrathecal morphine injected through the epidural catheter, because opioids act faster than local anesthetics
D) Plain ropivacaine 0.1%, because dilute solutions reach surgical density most quickly
E) Normal saline bolus, because volume expansion alone establishes surgical anesthesia
ANSWER: A
Rationale:
For rapid extension of an existing labor epidural to a cesarean surgical block, 3% chloroprocaine gives the fastest, most reliable onset, on the order of 6 to 10 minutes. Although chloroprocaine has a relatively unfavorable pKa, its very high concentration drives a large mass of drug across the nerve membrane by mass action, overcoming the ionization disadvantage and producing a quick dense block.
Option B: Option B is incorrect because a dilute bupivacaine solution is an analgesic concentration that does not produce rapid surgical-density block.
Option C: Option C is incorrect because epidural or intrathecal morphine is a slow-onset analgesic adjunct, not a surgical anesthetic, and would not establish operative block quickly.
Option D: Option D is incorrect because dilute ropivacaine is an analgesic concentration and is not the rapid surgical-block agent.
Option E: Option E is incorrect because saline contains no anesthetic and cannot establish surgical anesthesia.
8. In managing spinal anesthesia-induced hypotension during elective cesarean delivery, phenylephrine is generally preferred over ephedrine. Which statement best captures the basis for this preference and its expected trade-off?
A) Ephedrine is preferred because it raises maternal heart rate, and heart rate is the most important fetal outcome
B) Both agents are interchangeable, with no measured difference in fetal or maternal effects
C) Phenylephrine is preferred because it raises maternal heart rate more than ephedrine does
D) Phenylephrine is preferred because it better maintains uteroplacental blood flow and fetal acid-base status, with the expected trade-off of a lower maternal heart rate
E) Phenylephrine is avoided in obstetrics because its alpha activity dangerously reduces placental perfusion
ANSWER: D
Rationale:
Randomized evidence supports phenylephrine as the preferred vasopressor for spinal-induced hypotension at elective cesarean delivery because it better maintains uteroplacental perfusion and yields superior fetal acid-base status compared with ephedrine. The expected trade-off is a lower maternal heart rate, a reflex response to the rise in blood pressure that is generally well tolerated.
Option A: Option A is incorrect because maternal heart rate is not the governing fetal outcome, and ephedrine is associated with worse fetal acid-base status.
Option B: Option B is incorrect because the agents are not interchangeable; measured fetal differences are the reason for the preference.
Option C: Option C misstates the hemodynamics; phenylephrine tends to lower, not raise, maternal heart rate.
Option E: Option E inverts the evidence, which shows phenylephrine preserves rather than reduces uteroplacental flow.
9. Contemporary labor analgesia often uses programmed intermittent epidural bolus (PIEB) delivery rather than a continuous epidural infusion at the same hourly rate. What is the principal advantage of PIEB, and why does it occur?
A) PIEB delivers more total drug per hour, which is why analgesia improves
B) PIEB eliminates the need for any patient-controlled demand dosing because boluses never fail
C) PIEB produces more uniform spread of solution within the epidural space, reaching lateral recesses more completely, which yields better dermatomal coverage and lower local anesthetic consumption at equivalent total dose
D) PIEB works because intermittent boluses are absorbed systemically faster, raising plasma levels
E) PIEB and continuous infusion are pharmacologically identical, and any difference is purely a pump-programming convenience
ANSWER: C
Rationale:
The advantage of PIEB arises from the physics of delivery, not from giving more drug. A bolus injected under higher instantaneous pressure spreads more uniformly through the epidural space, reaching lateral and posterior recesses that a slow continuous flow tends to miss. The result is more complete dermatomal coverage, superior analgesia, and lower total local anesthetic consumption compared with a continuous infusion delivering the same hourly dose.
Option A: Option A is incorrect because the benefit is achieved at equivalent or lower total dose, not by giving more drug.
Option B: Option B is incorrect because PIEB is typically combined with patient-controlled demand dosing and does not render breakthrough dosing unnecessary.
Option D: Option D is incorrect because the mechanism is improved epidural spread, not faster systemic absorption, which would be undesirable.
Option E: Option E is incorrect because the delivery pattern produces a real pharmacodynamic difference in spread and coverage.
10. A patient develops a high spinal block with hypotension accompanied by bradycardia. In choosing vasopressor support for this specific combination, which agent is generally preferred and why, and what additional agent addresses the bradycardia?
A) Phenylephrine is preferred because its pure alpha effect corrects both the hypotension and the slow heart rate simultaneously
B) Ephedrine is preferred when bradycardia accompanies the hypotension because it provides both alpha and beta support, and atropine is used to treat vagally mediated bradycardia
C) An esmolol infusion is preferred to control the heart rate, with fluids alone for the pressure
D) Nitroglycerin is preferred to improve coronary flow during the high block
E) No vasopressor should be given; the block must simply be allowed to wear off without support
ANSWER: B
Rationale:
When hypotension from a high spinal is accompanied by bradycardia, ephedrine is generally preferred over phenylephrine because its combined alpha and beta activity supports both blood pressure and heart rate, whereas pure alpha agonism can further slow the heart through reflex mechanisms. Atropine is added to treat vagally mediated bradycardia arising from unopposed parasympathetic tone on the denervated heart.
Option A: Option A is incorrect because phenylephrine's pure alpha effect tends to lower heart rate reflexively and does not correct bradycardia.
Option C: Option C is incorrect because esmolol is a beta-blocker that would worsen both the bradycardia and the hypotension.
Option D: Option D is incorrect because nitroglycerin is a vasodilator that would deepen the hypotension.
Option E: Option E is incorrect and unsafe because a high spinal with hemodynamic compromise requires active resuscitative support, not passive observation.
11. To minimize the risk of post-dural puncture headache (PDPH) when performing a spinal anesthetic, which combination of needle characteristics is most protective, and what is the relationship between needle design and PDPH risk?
A) A large-gauge cutting (Quincke) needle, because a wider cutting tip seals the dura more effectively
B) A large-gauge pencil-point needle, because larger needles always reduce headache risk
C) A small-gauge cutting (Quincke) needle, because cutting tips uniformly cause less PDPH than pencil-point tips
D) Needle design has no bearing on PDPH; only patient age determines risk
E) A small-gauge pencil-point (Whitacre or Sprotte) needle, because at a given gauge pencil-point tips cause substantially less PDPH than cutting tips, and smaller gauge further lowers risk
ANSWER: E
Rationale:
Two needle features independently reduce PDPH risk: smaller gauge (a smaller dural hole leaks less CSF) and a pencil-point tip design (Whitacre or Sprotte), which spreads dural fibers rather than cutting them and produces substantially less PDPH than a cutting Quincke needle at the same gauge. The most protective choice therefore combines a small gauge with a pencil-point tip.
Option A: Option A is incorrect on both counts: a larger gauge increases risk, and cutting tips increase rather than decrease PDPH.
Option B: Option B is incorrect because larger needles increase, not decrease, the risk.
Option C: Option C is incorrect because cutting tips cause more, not less, PDPH than pencil-point tips.
Option D: Option D is incorrect because needle gauge and tip design are well-established determinants of PDPH risk, alongside patient factors such as age.
12. Two patients develop new neurologic deficits after neuraxial procedures. One deteriorates over a few hours and is anticoagulated; the other deteriorates over several days with fever and an elevated white count. Which option correctly distinguishes epidural hematoma from epidural abscess?
A) Epidural hematoma typically evolves rapidly over hours and is frequently associated with anticoagulation, whereas epidural abscess typically evolves more slowly over days, with fever, leukocytosis, and Staphylococcus aureus as the most common organism
B) Epidural hematoma evolves over days with fever, whereas epidural abscess evolves over hours in anticoagulated patients
C) Both conditions evolve identically over hours and cannot be distinguished by time course or systemic signs
D) Epidural abscess is a benign condition managed with observation, whereas hematoma requires antibiotics alone
E) Neither condition causes neurologic deficit, so the distinction is clinically unimportant
ANSWER: A
Rationale:
The two catastrophic neuraxial complications differ in tempo and accompanying features. Epidural hematoma usually develops rapidly, over hours, and is frequently linked to impaired hemostasis or anticoagulation; it presents as a progressive deficit without systemic infection signs. Epidural abscess usually evolves more slowly, over days, with fever, back pain, and leukocytosis preceding neurologic deterioration, and Staphylococcus aureus is the most common causative organism. Recognizing this distinction guides workup, though both require urgent imaging and decompression.
Option B: Option B reverses the time courses and associated features of the two conditions.
Option C: Option C is incorrect because time course and systemic signs do help distinguish them.
Option D: Option D is incorrect and dangerous because abscess is not benign and both conditions generally require urgent surgical decompression, not observation or antibiotics alone.
Option E: Option E is incorrect because both conditions can cause devastating neurologic deficits.
13. Neuraxial anticoagulation guidelines (such as those from the American Society of Regional Anesthesia and Pain Medicine, ASRA) specify minimum intervals between anticoagulant dosing and neuraxial procedures. Which statement correctly describes the scope of these intervals?
A) The intervals govern only the timing of needle insertion; once a catheter is in place it can be removed at any time without regard to anticoagulant dosing
B) The intervals apply only to the resumption of anticoagulation after surgery and have no bearing on placement
C) The intervals govern both needle or catheter placement and catheter removal, because removing a catheter at the wrong time relative to anticoagulant dosing carries a hematoma risk comparable to insertion
D) The intervals are identical for every anticoagulant regardless of class, dose, or renal function
E) The intervals apply only to patients who are not anticoagulated
ANSWER: C
Rationale:
A key and frequently underappreciated principle is that the anticoagulation timing intervals apply not only to needle and catheter placement but also to catheter removal. Withdrawing an epidural catheter disrupts epidural vessels just as insertion does, so removing it at the wrong time relative to anticoagulant dosing carries a hematoma risk comparable to insertion; the same intervals must therefore be observed at removal.
Option A: Option A is incorrect and dangerous because it ignores the well-established risk associated with catheter removal.
Option B: Option B is incorrect because the intervals govern placement and removal, not solely resumption of anticoagulation.
Option D: Option D is incorrect because the intervals vary by anticoagulant class, dose, and renal function rather than being uniform.
Option E: Option E is incorrect because these intervals are specifically relevant to patients who are receiving anticoagulants.
14. After a combined spinal-epidural (CSE) technique, why can the epidural catheter not be reliably tested for intrathecal placement immediately after the spinal injection, and what is the practical implication?
A) The spinal injection chemically inactivates any local anesthetic later given through the epidural catheter, so testing is pointless
B) The epidural catheter is always intrathecal after a CSE, so no testing is ever required
C) Testing is unnecessary because the spinal block guarantees the epidural catheter is correctly positioned
D) The motor block already produced by the spinal component masks the motor-block response that a test dose relies on to detect intrathecal placement, so catheter testing must be deferred until the spinal block has partially resolved
E) The epinephrine in the test dose is destroyed by CSF, so no test dose can ever be interpreted after a CSE
ANSWER: D
Rationale:
The CSE test-dose caveat follows directly from how the intrathecal marker works. A test dose detects intrathecal catheter placement by producing a rapid motor block; but immediately after a CSE, the spinal component has already produced dense lower-extremity motor block, which masks any additional motor response and makes the test uninterpretable. The practical implication is that catheter testing should be deferred until the spinal block has partially resolved, typically after some time has elapsed.
Option A: Option A fabricates chemical inactivation of subsequently injected drug.
Option B: Option B is incorrect because the catheter is intended to be epidural, not intrathecal, and placement is not guaranteed.
Option C: Option C is incorrect because a functioning spinal block does not confirm correct epidural catheter position.
Option E: Option E fabricates destruction of epinephrine by CSF and misstates why immediate testing is unreliable.
15. For a continuous peripheral nerve block (CPNB) infusion running over 48 to 72 hours, ropivacaine is generally preferred over bupivacaine. What is the principal reason for this preference?
A) Ropivacaine has a much faster onset, which matters most during a prolonged infusion
B) Ropivacaine offers a modestly wider cardiac safety margin with comparable analgesic efficacy, an advantage during extended infusions where drug accumulation is a concern
C) Ropivacaine is markedly more potent than bupivacaine, allowing far smaller total doses
D) Ropivacaine produces denser motor block, which is the goal of an analgesic infusion
E) Ropivacaine cannot accumulate during prolonged infusion regardless of patient hepatic function
ANSWER: B
Rationale:
Over an extended CPNB infusion, the chief concern is the consequence of drug accumulation, so the relevant advantage is safety. Ropivacaine is generally preferred because it carries a modestly wider cardiac safety margin than bupivacaine while providing comparable analgesic efficacy, which is reassuring when an agent is infused continuously for days.
Option A: Option A is incorrect because onset speed is not the governing consideration for a multi-day analgesic infusion.
Option C: Option C is incorrect because ropivacaine is not markedly more potent than bupivacaine; if anything it is somewhat less potent, and potency is not the basis for the preference.
Option D: Option D is incorrect because dense motor block is undesirable in an analgesic infusion intended to preserve function.
Option E: Option E is incorrect because any local anesthetic can accumulate during prolonged infusion, particularly with hepatic impairment, low cardiac output, or low body weight, which is precisely why the wider safety margin matters.
16. A postoperative patient with a thoracic epidural infusion develops unexpected lower-extremity motor weakness. What is the correct first step, and how does the response to that step guide the next decision?
A) Reduce or stop the infusion and reassess after a short interval: weakness that resolves is almost certainly pharmacologic and can be managed by lowering the concentration or rate, whereas weakness that persists or progresses requires urgent MRI to evaluate for epidural hematoma
B) Immediately remove the epidural catheter without regard to anticoagulant timing, since catheter removal cannot cause harm
C) Increase the infusion rate to overcome a presumed inadequate block, then observe overnight
D) Order urgent surgical decompression first, before any attempt to reduce the infusion or obtain imaging
E) Reassure the patient that motor weakness during an epidural infusion never requires evaluation
ANSWER: A
Rationale:
The correct initial maneuver for unexpected motor weakness during an epidural infusion is to reduce or stop the infusion and reassess after a short interval. If the weakness resolves, it was pharmacologic over-blockade and can be managed by adjusting concentration or rate. If the weakness persists or progresses despite stopping the infusion, that is a red flag for epidural hematoma and mandates urgent MRI and prompt neurosurgical evaluation. This stepwise logic distinguishes benign from dangerous causes. Option D is premature because decompression follows imaging confirmation and an assessment that the deficit is not simply pharmacologic, except where clinical suspicion is overwhelming.
Option B: Option B is incorrect and dangerous because catheter removal in an anticoagulated patient itself carries hematoma risk and must observe the same timing intervals.
Option C: Option C is incorrect because increasing the infusion would deepen a pharmacologic block and could mask a developing hematoma.
Option E: Option E is incorrect and unsafe because progressive motor weakness can signal a neurosurgical emergency and always warrants evaluation.
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials that are believed reliable and consistent with standards accepted at the time of development.
Possibility of error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete.
Users should confirm the information contained herein with other sources.
This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site.
Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals.
Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.
Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.